V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
G
GMABAI Stock Diagnostic Report

Genmab, Incyte team up to develop experimental colorectal cancer treatment

Jenmap and Insight announced a combined clinical collaboration on the progressive pelvic cancer treatment drug, which is positive but has limited impact as it remains in the early stage.

View Source Article ↗
AI CATALYST SCORE60 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

GMAB Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-10-25 19:00:44GMAB60MidView Report →
2026-10-25 11:15:41GMAB50MidView Report →
2026-10-06 16:52:10GMAB62MidView Report →
View Full History for GMAB (Blueprint) →